EditorialEditorial
Fluorodeoxyglucose Positron Emission Tomography for Giant Cell Arteritis
DANIEL BLOCKMANS
The Journal of Rheumatology December 2017, 44 (12) 1763-1764; DOI: https://doi.org/10.3899/jrheum.170966
DANIEL BLOCKMANS
Katholieke Universiteit Leuven, General Internal Medicine, Leuven,
Belgium.
MD, PhDREFERENCES
- 1.↵
- 2.↵
- 3.↵
- Grayson PC,
- Maksimowicz-McKinnon K,
- Clark TM,
- Tomasson G,
- Cuthbertson D,
- Carette S,
- et al.
- 4.↵
- 5.↵
- 6.↵
- Tuckwell K,
- Collinson N,
- Dimonaco S,
- Klearman M,
- Blockmans D,
- Brouwer E,
- et al.
- 7.↵
- Stone JH,
- Tuckwell K,
- Dimonaco S,
- Klearman M,
- Aringer M,
- Blockmans D,
- et al.
- 8.↵
- 9.↵
- 10.↵
- Clifford AH,
- Murphy EM,
- Burrell SC,
- Bligh MP,
- MacDougall RF,
- Heathcote JG,
- et al.
- 11.↵
- Le Pendu C,
- Meignin V,
- Gonzalez-Chiappe S,
- Hij A,
- Galateau-Sallé F,
- Mahr A
In this issue
The Journal of Rheumatology
Vol. 44, Issue 12
1 Dec 2017
Fluorodeoxyglucose Positron Emission Tomography for Giant Cell Arteritis
DANIEL BLOCKMANS
The Journal of Rheumatology Dec 2017, 44 (12) 1763-1764; DOI: 10.3899/jrheum.170966